Tuberculin conversion in HIV seropositives

Journal of the Indian Medical Association

Volumn 100, Issue 10, 2002, Pages 622-623

  Laxman, Y ^a  

^a Bangalore Medical College and Research Institute   (India)

Author keywords

HIV; Immunity; Mycobacterium w; Tuberculin conversion; Tuberculosis

Indexed keywords

EPITOPE; IMMUNOMODULATING AGENT; IMMUVAC; TUBERCULIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATYPICAL MYCOBACTERIUM; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; DELAYED HYPERSENSITIVITY; DISEASE ASSOCIATION; EPIDEMIC; ERYTHEMA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM W; PROPHYLAXIS; SKIN INDURATION; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0036808419     PISSN: 00195847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Hopewell PC - Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management, and control of tuberculosis. Clin Infect Dis 1992; 15: 540-7.
2. Telzak EE - Tuberculosis and human immunodeficiency virus infection. Med Clin North Am 1997; 81: 345-60.
3. Markowitz N, Hansen NI, Hopewell PC, Glassroth J, Kvale PA, Mangura BT, et al - Incidence of tuberculosis in the United States among HIV-infected persons: The pulmonary complications of HIV Infection Study Group. Ann Intern Med 1997; 126: 123-32.
4. Centre for Disease Control and Prevention (MMWR 2000; 49: 685-687). Missed opportunities for prevention of tuberculosis among persons with HIV infections - Select locations, United States 1996-97. JAMA 2000; 284: 1641-2.
5. Whalen CC, et al - A trial of three regimen to prevent tuberculosis in Ugandan adults infected with human immunodeficiency virus. N Engl J Med 1997; 337: 801-8.
6. Marsh BJ, Fordham von Reyn C, Arbei RD, Morin P -Immunization of HIV-infected adults with a three-dose series of inactivated Mycobacterium vaccae. Am J Med Sci 1997; 313: 377-83.
7. von Reyn CF, Arbeit RD, Yeaman G, Waddell RD, Marsh BJ, Morin P, et al - Immunization of healthy adult subjects in the United States with inactivated Mycobacterium vaccae administered in a three-dose series. Clin Infect Dis 1997; 24: 843-8.
8. Yadava A, Mukherjee R - An immunodominant 30-kDa antigen of a candidate anti-leprosy vaccine, mycobacterium w, shares T and B cell determinants with M leprae and M tuberculosis. Med Microbiol Immunol (Berl) 1993; 182: 243-53.
9. Talwar GP - An immunotherapeutic vaccine for multibacillary leprosy. Int Rev Immunol 1999; 18: 229-49.
10. Patel N, Deshpande MM, Shah M - Effect of an immunomodulator containing mycobacterium w on sputum conversion in pulmonary tuberculosis. J Indian Med Assoc 2002; 100: 191-3.
11. Silveira H. Ordway D. Dockrell H, Jackson M, Ventura F - Cell-mediated immune responses to mycobacterial antigens in patients with pulmonary tuberculosis and HIV infection. Clin Exp Immunol 1997; 110: 26-34.
12. Kharkar RD - Treatment of AIDS. J Indian Med Assoc 2002; 100: 203.
13. Muller HK, Pye DW, Martin CL, Kimpton WG - Tuberculin anergy in clinically normal individuals. I. Lymphokine and lymphocyte transformation studies. Int Arch Allergy Appl Immunol 1983; 70: 65-70.
14. Delgado JC, Tsai EY, Thim S, Baena A, Boussiotis VA, Reynes JM, et al - Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia. Proc Natl Acad Sci USA 2002; 99: 7576-81.
15. Boullier S, Poquet Y, Debord T, Fournie JJ, Gougeon ML -Regulation by cytokines (IL-12, IL-15, IL-4 and IL-10) of the Vgamma9 Vdelta2 T cell response to mycobacterial phosphoantigens in responder and anergic HIV-infected persons. Eur J Immunol 1999; 29: 90-9.